methylene blue has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biondo, E; Clark, ME; Cormack, LK; Gonzalez-Lima, F; Hardy, GA; Kraan, DJ; Lee, HJ; Monfils, M; Smith, ES | 1 |
| Biju, KC; Carlisle, DCB; Clark, RA; Evans, RC; Gelfond, J; Shrestha, K | 1 |
2 other study(ies) available for methylene blue and Parkinsonian Disorders
| Article | Year |
|---|---|
Daily consumption of methylene blue reduces attentional deficits and dopamine reduction in a 6-OHDA model of Parkinson's disease.
Topics: Animals; Antioxidants; Attention; Behavior, Animal; Dopamine; Dopaminergic Neurons; Male; Methylene Blue; Neuroprotective Agents; Parkinsonian Disorders; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2017 |
Methylene Blue Ameliorates Olfactory Dysfunction and Motor Deficits in a Chronic MPTP/Probenecid Mouse Model of Parkinson's Disease.
Topics: Animals; Antioxidants; Behavior, Animal; Brain; Dopaminergic Neurons; Male; Methylene Blue; Mice; Mice, Inbred C57BL; Motor Activity; Neuroprotective Agents; Parkinsonian Disorders; Smell | 2018 |